Matt Morgan, MD
Allergy & Immunology · Las Vegas, NVNPI 1962403154
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.5% of the total across 474 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 34 manufacturers reported payments, led by AstraZeneca at 27.3% of the total. 2025 is the largest year on record at $3,064, 3.5 times the $874 reported in 2019.
Across 474 payments — averaging $25.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- GSK$2K
- Regeneron Healthcare Solutions, Inc.$1K
- Pfizer$869
- Takeda Pharmaceuticals U.S.A., Inc.$801
- CSL Behring$618
- plus $3K from 28 others
What the payments were for
- Consulting fees$951%
- Food & beverage$11,59098%
- Education$2012%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 97 | $3,248 |
| GSK | 80 | $2,032 |
| Regeneron Healthcare Solutions, Inc. | 36 | $1,162 |
| Pfizer | 42 | $869 |
| Takeda Pharmaceuticals U.S.A., Inc. | 40 | $801 |
| CSL Behring | 36 | $618 |
| Sanofi | 19 | $581 |
| Novartis | 13 | $284 |
| Optinose US, Inc. | 8 | $221 |
| Amgen | 9 | $205 |
| Biocryst US Sales Co., LLC | 14 | $203 |
| Grifols USA, LLC | 9 | $202 |
| LEO Pharma Inc. | 8 | $154 |
| Genentech USA, Inc. | 9 | $148 |
| Pharming Healthcare, Inc. | 7 | $132 |
| AbbVie | 5 | $129 |
| Sanofi-aventis U.S. LLC | 5 | $126 |
| Kaleo, Inc. | 5 | $117 |
| ADMA Biomanufacturing LLC | 8 | $95 |
| Teva Pharmaceuticals USA, Inc. | 4 | $77 |
| Incyte Corporation | 3 | $59 |
| Regeneron | 1 | $57 |
| Aimmune Therapeutics, Inc. | 2 | $50 |
| Merck | 2 | $49 |
| Galderma Laboratories, L.p. | 2 | $46 |
| Tersera Therapeutics LLC | 1 | $39 |
| Organon | 2 | $29 |
| Mylan Specialty L.p. | 1 | $27 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $25 |
| GC Biopharma USA, Inc. | 1 | $24 |
| Shire North American Group Inc | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
| Covis Pharma GmbH | 1 | $17 |
| Ionis Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few allergy & immunology providers in Nevadato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 43 | $208,593 |
| Epinephrine | 11 | $1,777 |
| Azelastine Hcl | 64 | $1,629 |
| Ipratropium Bromide | 19 | $1,395 |
| Montelukast Sodium | 59 | $425 |
| Doxepin Hcl | 18 | $408 |
| Fluticasone Propionate | 28 | $274 |
| Prednisone | 11 | $30 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Las Vegas
- Jason BellakLas Vegas$41K
- Ricardo VinuyaLas Vegas$36K
- Anthony NguyenLas Vegas$9K
- Frank McAllisterLas Vegas$905
- Joram SeggevLas Vegas$423
- Victor CohenLas Vegas$309
- Frederick HermanHenderson$35K
- Jeffrey NugentReno$12K
- Reece JonesReno$9K
- Andrew McKnightHenderson$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.